Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation
Background. In the recent ESC/EACTS guidelines, left atrial appendage (LAA) occlusion or exclusion in patients undergoing (thoracoscopic) atrial fibrillation (AF) ablation surgery is recommended. The Watchman device (WD, Boston Scientific, Minnesota) has proved to reduce the risk of thromboembolic e...
Saved in:
| Main Authors: | Mindy Vroomen, Bart Maesen, Justin G. Luermans, Harry J. Crijns, Jos G. Maessen, Mark La Meir, Laurent Pison |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Journal of Interventional Cardiology |
| Online Access: | http://dx.doi.org/10.1155/2019/4525084 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Left atrial appendage closure with Watchman device in prevention of thromboembolic complications in patients with atrial fibrillation: First experience in Serbia
by: Nedeljković Milan A., et al.
Published: (2017-01-01) -
Therapeutic Dilemma of Natural Watchman: Congenital Absence of the Left Atrial Appendage
by: Phoo Pwint Nandar, et al.
Published: (2018-01-01) -
Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation
by: Taral K. Patel, et al.
Published: (2012-01-01) -
Current Status of Left Atrial Appendage Thrombus with Atrial Fibrillation
by: Zhihong Zhao, et al.
Published: (2023-09-01) -
Comparative Endothelialization of the Watchman Plug Device and LACBES Pacifier Occluder after Left Atrial Appendage Closure
by: Jing Zhou, et al.
Published: (2024-12-01)